Novel estrogen receptor beta agonist S-equol decreases tumor proliferation in patients with triple negative breast cancer (TNBC).Kate Lathrop, Richard Elledge, Alia Nazarullah et al.|Journal of Clinical Oncology|2020Cited by 12
Abstract PS5-31: Molecular markers of response to s-equol, a novel oral estrogen receptor (ER) beta agonist for triple negative breast cancerKate Lathrop, Richard Elledge, Virginia Kaklamani et al.|Cancer Research|2021Cited by 2